Skip to main content
Log in

Comment on: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations

  • Letter to the Editor
  • Published:
Drugs Aims and scope Submit manuscript

The Original Article was published on 16 September 2022

A Letter to the Editor to this article was published on 01 September 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Veronese N, Cooper C, Bruyere O, Al-Daghri NM, Branco J, Cavalier E, et al. Multimodal multidisciplinary management of patients with moderate to severe pain in knee osteoarthritis: a need to meet patient expectations. Drugs. 2022;82(13):1347–55.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wang Q, Chen Q, Sui J, Tu Y, Guo X, Li F. Celecoxib prevents tumor necrosis factor-alpha (TNF-alpha)-induced cellular senescence in human chondrocytes. Bioengineered. 2021;12(2):12812–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Abrams GD, Chang W, Dragoo JL. In vitro chondrotoxicity of nonsteroidal anti-inflammatory drugs and opioid medications. Am J Sports Med. 2017;45(14):3345–50.

    Article  PubMed  Google Scholar 

  4. Liu B, Ji C, Shao Y, Liang T, He J, Jiang H, et al. Etoricoxib decreases subchondral bone mass and attenuates biomechanical properties at the early stage of osteoarthritis in a mouse model. Biomed Pharmacother. 2020;127: 110144.

    Article  CAS  PubMed  Google Scholar 

  5. Perry TA, Wang X, Nevitt M, Abdelshaheed C, Arden N, Hunter DJ. Association between current medication use and progression of radiographic knee osteoarthritis: data from the osteoarthritis initiative. Rheumatology (Oxford). 2021;60(10):4624–32.

    Article  CAS  PubMed Central  Google Scholar 

  6. Simic M, Harmer AR, Agaliotis M, Nairn L, Bridgett L, March L, et al. Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study. Arthritis Res Ther. 2021;23(1):160.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Toda K. Intra-articular non-steroidal anti-inflammatory drugs may promote cartilage degeneration. J Clin Pharm Ther. 2022;47(9):1491.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katsuhiro Toda.

Ethics declarations

Conflicts of interest/Competing interests

KT’s child is an employee of Nippon Zoki Pharmaceutical Co., Ltd.

Ethics approval

Not required for this article type.

Data and code availability statement

N/A.

Author contributions

KT is the only author.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toda, K. Comment on: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations. Drugs 82, 1511–1512 (2022). https://doi.org/10.1007/s40265-022-01792-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40265-022-01792-2

Navigation